A randomized phase II study with ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in synchronous metastatic renal cell carcinoma

Magnus Lindskog, Anna Laurell, Anders Kjellman, Bohuslav Melichar, Jacek Niezabitowski, Pablo Maroto, Henryk Zielinski, Felipe Villacampa, Pierre Bigot, Zoltan Bajory, Omi Parikh, David Vazquez Alba, Asa Jellvert, Tibor Flasko, Enrique Gallardo Diaz, Maria Jose Ribal, Gunta Purkalne, Peter Suenaert, Alex Karlsson-Parra, Borje Ljungberg

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number11
JournalJournal of Clinical Oncology
Volume38
Issue number5 Supplement
Publication statusPublished - 10 Feb 2020
Externally publishedYes
EventASCO-SITC Clinical Immuno-Oncology Symposium - Orlando, United States
Duration: 6 Feb 20208 Aug 2020

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this